Open and Percutaneous Trigeminal Nucleotractotomy: A Case Series and Literature Review

Abstract

<b><i>Introduction:</i></b> Nucleotractotomy is an efficient surgical technique that provides a high pain relief rate for specific clinical indications. There are two main approaches for performing this operation: an open and percutaneous technique. <b><i>Methods:</i></b> In the Federal Center of Neurosurgery (Novosibirsk, Russia) from 2016 to 2022, 13 trigeminal nucleotractotomies (7 open and 6 percutaneous) were performed in 12 patients (5 women and 7 men). The indications for surgery were deafferentation pain and chronic drug-resistant pain syndrome caused by malignancy in the facial region. A neurological examination was done on each patient 1 day before the surgery, right after the surgery, and at the follow-up (examinations were done after 1, 6, and 12 months, or when the patient independently applied to our hospital). In the early postoperative period, patients underwent brain MRI. <b><i>Results:</i></b> The average pain intensity score before nucleotractotomy on the 11-point (0–10) visual analog scale (VAS) was 9.3. The effectiveness of open interventions was somewhat higher; the average VAS score in the early postoperative period for the open technique was 1.57, in the group of patients who underwent percutaneous nucleotractotomy were 2.66. Complete regression of the pain syndrome was achieved in 6 patients; in 5 patients, the pain in the face decreased by more than 50%. One case had an unsatisfactory outcome. In the open-surgery group in the early postoperative period, according to MRI, the average length of the visualized area of signal change was longer (21.5 mm, the average diameter was 3.75 mm) than in a percutaneous nucleotractotomy group (16 mm, the average diameter was 3.75 mm). During the postoperative period (average follow-up 40 months), the pain recurred in 3 patients (30%): 2 patients after percutaneous nucleotractotomy (3 and 18 months after surgery) and in 1 patient 4 months after the open surgery. The mean VAS score at the last follow-up was 2.6. <b><i>Conclusion:</i></b> Trigeminal nucleotractotomy is an effective approach to the treatment of intractable facial pain. Our experience suggests this technique is highly effective in patients with drug-resistant pain caused by craniofacial tumors and deafferentation conditions after treating trigeminal neuralgia.

Computed tomography-guided trigeminal tractotomy-nucleotomy for refractory chronic craniofacial pain: a case report

“…Gurbani et al reported a case involving multiple interventions, including gamma knife radiotherapy, percutaneous balloon trigeminal rhizotomy, and microvascular decompression. The patient returned to baseline pain levels at 1 month post-tractotomy [14]. Anisimov et al presented a case with minimal pain reduction (VAS reduction from 10 to 8) after percutaneous nucleotractotomy for deafferentiation pain following a surgical attempt to treat trigeminal neuralgia [15].…”